Bank of New York Mellon Corp - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 109 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$7,197
-20.8%
34,188
-39.8%
0.00%
Q1 2023$9,089
-71.2%
56,8040.0%0.00%
Q4 2022$31,526
-55.0%
56,804
-3.2%
0.00%
Q3 2022$70,000
+89.2%
58,6990.0%0.00%
Q2 2022$37,000
-87.7%
58,699
-77.8%
0.00%
Q1 2022$301,000
-49.6%
264,479
-0.4%
0.00%
Q4 2021$597,000
-33.1%
265,409
+1.6%
0.00%
Q3 2021$893,000
+25.6%
261,357
+9.9%
0.00%
Q2 2021$711,000
+248.5%
237,735
+277.1%
0.00%
Q1 2021$204,000
+38.8%
63,037
-9.3%
0.00%
Q4 2020$147,000
+81.5%
69,5040.0%0.00%
Q3 2020$81,000
+28.6%
69,504
-0.0%
0.00%
Q2 2020$63,000
+8.6%
69,5050.0%0.00%
Q1 2020$58,000
-13.4%
69,505
-0.6%
0.00%
Q4 2019$67,000
-6.9%
69,9180.0%0.00%
Q3 2019$72,000
-42.9%
69,9180.0%0.00%
Q2 2019$126,000
-3.8%
69,9180.0%0.00%
Q1 2019$131,000
+54.1%
69,918
-3.2%
0.00%
Q4 2018$85,000
-24.8%
72,256
+73.6%
0.00%
Q3 2018$113,000
+41.2%
41,6340.0%0.00%
Q2 2018$80,000
-23.1%
41,634
-15.9%
0.00%
Q1 2018$104,000
+22.4%
49,517
+18.9%
0.00%
Q4 2017$85,000
+39.3%
41,634
-9.5%
0.00%
Q3 2017$61,000
-12.9%
45,985
+1.6%
0.00%
Q2 2017$70,000
-87.3%
45,267
-73.5%
0.00%
Q1 2017$551,000
+139.6%
170,649
+0.3%
0.00%
Q4 2016$230,000
-30.7%
170,206
-20.1%
0.00%
Q3 2016$332,000
-1.2%
213,139
-16.1%
0.00%
Q2 2016$336,000
-73.9%
254,019
+4.0%
0.00%
Q1 2016$1,287,000
-24.6%
244,143
+12.2%
0.00%
-100.0%
Q4 2015$1,707,000
-15.0%
217,574
-8.5%
0.00%0.0%
Q3 2015$2,009,000
-36.5%
237,780
-17.7%
0.00%0.0%
Q2 2015$3,163,000
-25.2%
288,960
-4.5%
0.00%0.0%
Q1 2015$4,229,000
-15.4%
302,574
+2.3%
0.00%0.0%
Q4 2014$4,997,000
+22.9%
295,851
-2.3%
0.00%0.0%
Q3 2014$4,065,000
-38.8%
302,906
-42.0%
0.00%0.0%
Q2 2014$6,646,000
+85.7%
521,802
+73.4%
0.00%0.0%
Q1 2014$3,578,000
+2.2%
300,839
+18.7%
0.00%0.0%
Q4 2013$3,500,000
-59.8%
253,455
-49.2%
0.00%0.0%
Q3 2013$8,700,000
+142.9%
499,164
+125.6%
0.00%0.0%
Q2 2013$3,582,000221,2140.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders